Treatment with the ALK inhibitor of mice injected with sorted by
relevance

Admin27.07.2021

Treatment with the ALK inhibitor of mice injected with

907
Admin19.07.2021

Treatment with the ALK inhibitor of mice injected with

3908
Admin23.08.2021

ALK is detected in melanoma samples. (a

8305
Admin03.09.2021

The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes

5209
Admin21.07.2021

Discovery and Characterization of Recurrent, Targetable

9000
Admin02.09.2021

LRRC4 combined with TMZ treatment prolonged mouse survival

8405
Admin18.09.2021

ALK RNA and protein levels increase after gefitinib

8308
Admin07.08.2021

Pharmacologic inhibition of PI3K p110δ in mutant Shp2E76K

3703
Admin17.08.2021

Effects of CI-994 histone deacetylase inhibitor treatment

4407
Admin14.09.2021

The ALK Inhibitor Ceritinib Overcomes Crizotinib

3000
Admin20.09.2021

ALK inhibitor-resistant cells exhibit stable resistance in

15010
Admin25.07.2021

Mice were injected with 10⁶ tumor cells in the left

3507
Admin11.09.2021

Cbl inhibitor treatment attenuates acute ulcerative

7602
Admin15.08.2021

Combined treatment with ENTPD2 inhibitor and anti-PD-1

Admin07.08.2021

DMOG treatment does not protect p50 -/-mice from LPS

Admin07.10.2021

Treatment of mice with the SPPL2a inhibitor 40 leads to a

5107
Admin07.09.2021

Pharmacological treatment with XPO1 inhibitors reduces

5207
Admin30.07.2021

Reduced PAK1 activity sensitizes FA/BRCA-proficient breast

7605
Admin06.10.2021

XPO-1 inhibitor SXR resensitizes BT474 xenograft tumors to

4805
Admin11.08.2021

FAK inhibitor protects lung fibrosis in bleomycin

6006
Admin24.08.2021

Proteasome inhibition after continuous treatment in vitro

905